U.S. is poised to issue a proposed rule that would subject outbound licensing deals with Chinese biotech companies to additional scrutiny
Back to Lifestyle
Lifestyle
October 22, 2026 at 1:42 PM
STAT+: Pharmalittle: We’re reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage, and more
STAT News
Excerpt from STAT News.